PRDM1 and neoplasm: We discovered that PRDM1 KO CAR T-cells chronically challenged with tumor targets display upregulation of a battery of exhaustion-associated transcription factors, including those belonging to the NR4A and TOX families which are reported to drive a cell-intrinsic program of T-cell hyporesponsiveness (50).